About Global Vascular
Global Vascular is a company based in Tokyo (Japan) founded in 2022 by Shunto Maegawa and Kenta Bito. Global Vascular has raised $6.91 million across 2 funding rounds from investors including Medikit, Diamond Medino Capital and TANAKA. Global Vascular operates in a competitive market with competitors including S3V Vascular Technologies, Elixir Medical, Medfavour and iVascular, among others.
- Headquarter Tokyo, Japan
- Founders Shunto Maegawa, Kenta Bito
-
Sectors
Healthcare
-
Phone
Locked
-
Website
Locked
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Total Equity Funding
$6.91 M (USD)
in 2 rounds
-
Latest Funding Round
$6.91 M (USD), Series B
Jun 30, 2025
-
Investors
Medikit
& 9 more
-
Employee Count
Not available
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Funding Insights of Global Vascular
Global Vascular has successfully raised a total of $6.91M across 2 strategic funding rounds. The most recent funding activity was a Series B round of $6.91 million completed in June 2025. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in Global Vascular
Global Vascular has secured backing from 10 investors, including venture fund and institutional investors. Prominent investors backing the company include Medikit, Diamond Medino Capital and TANAKA.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Diamond Medino Capital is focused on healthcare venture investments.
|
Locked | Locked | Locked | |
|
-
|
Locked | Locked | Locked | |
|
Venture capital is invested in AI, energy, and various sectors.
|
Locked | Locked | Locked |
Investor details for Global Vascular
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Global Vascular
Investment portfolio details for Global Vascular
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Global Vascular
Detailed financials for Global Vascular
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Global Vascular Comparisons
Peer comparison for Global Vascular
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Global Vascular
Global Vascular operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as S3V Vascular Technologies, Elixir Medical, Medfavour and iVascular, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Cardiovascular surgical and critical care devices are developed and offered.
|
|
| Locked | Locked | Locked |
Drug eluting stents
|
|
| Locked | Locked | Locked |
Develops innovative technologies for drug-eluting stents to treat cardiac disorders.
|
|
| Locked | Locked | Locked |
Develops vascular medical devices for coronary, peripheral, and neurointerventionism treatments.
|
Detailed competitors of Global Vascular
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Global Vascular
Complete news archive for Global Vascular
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Global Vascular
Global Vascular was founded in 2022 and raised its 1st funding round 1 year after it was founded.
Global Vascular is headquartered in Tokyo, Japan. It is registered at Tokyo, Tokyo, Japan.
Kenta Bito is the current CEO of Global Vascular. They have also founded this company.
Global Vascular is a funded company, having raised a total of $6.91M across 2 funding rounds to date.
Global Vascular was founded in 2022 and is based in Tokyo, Japan. Focus is placed on the medical device sector, specifically the development of a drug-eluting stent delivery system targeted at lower limb artery disease. The system incorporates BIOZONE Coating technology, a nanotechnology designed to reduce thrombus adhesion and the release of nickel ions. Endovascular treatments for affected patients are thereby facilitated through this approach.
Global Vascular's top competitors include S3V Vascular Technologies, Elixir Medical and Medfavour.
Global Vascular has 10 investors. Key investors include Medikit, Diamond Medino Capital, TANAKA, FTI, and Tokyo University of Science Innovation Capital.